Similar Posts
Dignify Therapeutics Announces the Issuance of US Patent No. 10,086,034 for treatment of voiding dysfunction
ByadminRESEARCH TRIANGLE PARK, NC (RTP) – October 18, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announces the issuance of US Patent No. 10,086,034, which relates to pharmacological methods of inducing urination and defecation. Dr. Karl Thor, Chief Scientific Officer and patent co-inventor stated “This is an important…
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
ByjwelchCompany RESEARCH TRIANGLE PARK, NC (October 22, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into…
True Stories of the Challenges of Neurological Conditions and Bladder and Bowel Programs – Laurie’s Story
Laurie’s Story December 14, 2005, started out like every other workday. I needed to get dressed, but decided to fix my coffee first and that is when I realized something was different. I was stirring my coffee and both my feet began to tingle as if they were asleep. I tried stomping my feet on…
Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH)
RESEARCH TRIANGLE PARK, NC (September 19, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research grants from the NIH. These grants add to the previous $20 million in research funding the company has received to advance multiple therapeutics for bladder and bowel disorders. Grants…
Troy Russell’s Spinal Cord Injury Story
In August 2012, Troy Russell, a scholar athlete, broke two vertebrae in his neck in a diving accident at a Narragansett, RI beach. The break in his neck resulted in an initial loss of mobility to his legs and arms. Over time and through a lot of hard work, Troy has improved physically. Today, he…
Dignify Therapeutics’ Chief Scientific Officer invited to participate at CURE-UAB
Dignify Therapeutics’ Chief Scientific Officer, Karl B. Thor, PhD, has been invited to participate as a Faculty member at the 2nd International Congress on Underactive Bladder – CURE-UAB in Denver, CO, Dec. 3-4, 2015. His presentation is entitled “Pharmaceutical Targets for Drug-induced Voiding”. This NIH-sponsored congress brings together academic, pharmaceutical, and medical device experts to…


